Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
United States
Male only
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Emily Buchanan
Colorado Research Center